Ratchaphruek Hospital Public Company Limited Stocks

THB 4.88Last Updated 26.01.2026

Issuer Rating

4/7

Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

THB 83.35M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
THB 4.88
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Ratchaphruek Hospital Public Company Limited engages in the hospital business under the Ratchaphruek Hospital name in Thailand. The company provides medical services in the field of internal medicine, such as dermatology, neurology, hematology, pulmonary, rheumatology, gastroenterology, nephrology, diabetes and endocrine, and cardiology; general, urological, and colorectal surgeries; and pediatrics, orthopedics, otorhinolaryngology, ophthalmology, obstetrics and gynecology,...

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks